163 related articles for article (PubMed ID: 7579416)
1. Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain.
Kanno H; Morimoto M; Fujii H; Tsujimura T; Asai H; Noguchi T; Kitamura Y; Miwa S
Blood; 1995 Oct; 86(8):3205-10. PubMed ID: 7579416
[TBL] [Abstract][Full Text] [Related]
2. Delayed onset of hemolytic anemia in CBA-Pk-1slc/Pk-1slc mice with a point mutation of the gene encoding red blood cell type pyruvate kinase.
Tsujino K; Kanno H; Hashimoto K; Fujii H; Jippo T; Morii E; Lee YM; Asai H; Miwa S; Kitamura Y
Blood; 1998 Mar; 91(6):2169-74. PubMed ID: 9490705
[TBL] [Abstract][Full Text] [Related]
3. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.
Wang C; Chiarelli LR; Bianchi P; Abraham DJ; Galizzi A; Mattevi A; Zanella A; Valentini G
Blood; 2001 Nov; 98(10):3113-20. PubMed ID: 11698298
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without host irradiation.
Morimoto M; Kanno H; Asai H; Tsujimura T; Fujii H; Moriyama Y; Kasugai T; Hirono A; Ohba Y; Miwa S; Kitamura Y
Blood; 1995 Dec; 86(11):4323-30. PubMed ID: 7492793
[TBL] [Abstract][Full Text] [Related]
5. Hereditary hemolytic anemia caused by diverse point mutations of pyruvate kinase gene found in Japan and Hong Kong.
Kanno H; Wei DC; Chan LC; Mizoguchi H; Ando M; Nakahata T; Narisawa K; Fujii H; Miwa S
Blood; 1994 Nov; 84(10):3505-9. PubMed ID: 7949104
[TBL] [Abstract][Full Text] [Related]
6. [Molecular basis and pathophysiology of red cell enzymopathies].
Kanno H
Nihon Rinsho; 1996 Sep; 54(9):2382-9. PubMed ID: 8890566
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of the PK-LR gene in pyruvate kinase deficient Spanish patients. Red Cell Pathology Group of the Spanish Society of Haematology (AEHH).
Zarza R; Alvarez R; Pujades A; Nomdedeu B; Carrera A; Estella J; Remacha A; Sánchez JM; Morey M; Cortes T; Pérez Lungmus G; Bureo E; Vives Corrons JL
Br J Haematol; 1998 Nov; 103(2):377-82. PubMed ID: 9827908
[TBL] [Abstract][Full Text] [Related]
8. Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency.
Kanno H; Fujii H; Wei DC; Chan LC; Hirono A; Tsukimoto I; Miwa S
Blood; 1997 Jun; 89(11):4213-8. PubMed ID: 9166866
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell PK deficiency: An update of PK-LR gene mutation database.
Canu G; De Bonis M; Minucci A; Capoluongo E
Blood Cells Mol Dis; 2016 Mar; 57():100-9. PubMed ID: 26832193
[TBL] [Abstract][Full Text] [Related]
10. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.
Zanella A; Bianchi P
Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):57-81. PubMed ID: 10916678
[TBL] [Abstract][Full Text] [Related]
11. Molecular modelling of human red blood cell pyruvate kinase: structural implications of a novel G1091 to a mutation causing severe nonspherocytic hemolytic anemia.
van Solinge WW; Kraaijenhagen RJ; Rijksen G; van Wijk R; Stoffer BB; Gajhede M; Nielsen FC
Blood; 1997 Dec; 90(12):4987-95. PubMed ID: 9389718
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of canine pyruvate kinase deficiency.
Whitney KM; Goodman SA; Bailey EM; Lothrop CD
Exp Hematol; 1994 Aug; 22(9):866-74. PubMed ID: 7520391
[TBL] [Abstract][Full Text] [Related]
13. Transgenic rescue of hemolytic anemia due to red blood cell pyruvate kinase deficiency.
Kanno H; Utsugisawa T; Aizawa S; Koizumi T; Aisaki K; Hamada T; Ogura H; Fujii H
Haematologica; 2007 Jun; 92(6):731-7. PubMed ID: 17550844
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of PK-LR gene in pyruvate kinase-deficient Italian patients.
Zanella A; Bianchi P; Baronciani L; Zappa M; Bredi E; Vercellati C; Alfinito F; Pelissero G; Sirchia G
Blood; 1997 May; 89(10):3847-52. PubMed ID: 9160692
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: a single amino acid substitution near the active site and decreased mRNA content of the R-type PK.
Kanno H; Fujii H; Tsujino G; Miwa S
Biochem Biophys Res Commun; 1993 Apr; 192(1):46-52. PubMed ID: 8476433
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate kinase deficiency.
Miwa S; Fujii H
Clin Biochem; 1990 Apr; 23(2):155-7. PubMed ID: 2197027
[TBL] [Abstract][Full Text] [Related]
17. Eight novel mutations and consequences on mRNA and protein level in pyruvate kinase-deficient patients with nonspherocytic hemolytic anemia.
Kugler W; Willaschek C; Holtz C; Ohlenbusch A; Laspe P; Krügener R; Muirhead H; Schröter W; Lakomek M
Hum Mutat; 2000; 15(3):261-72. PubMed ID: 10679942
[TBL] [Abstract][Full Text] [Related]
18. Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.
van Wijk R; Huizinga EG; van Wesel AC; van Oirschot BA; Hadders MA; van Solinge WW
Hum Mutat; 2009 Mar; 30(3):446-53. PubMed ID: 19085939
[TBL] [Abstract][Full Text] [Related]
19. cDNA cloning of human R-type pyruvate kinase and identification of a single amino acid substitution (Thr384----Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia.
Kanno H; Fujii H; Hirono A; Miwa S
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8218-21. PubMed ID: 1896471
[TBL] [Abstract][Full Text] [Related]
20. Hematologically important mutations: red cell pyruvate kinase (2nd update).
Baronciani L; Bianchi P; Zanella A
Blood Cells Mol Dis; 1998 Sep; 24(3):273-9. PubMed ID: 10087985
[No Abstract] [Full Text] [Related]
[Next] [New Search]
